Dr. Ryan Cassaday of Seattle Cancer Care Alliance presented a poster at the 2015 ASH Annual Meeting in Orlando. In the following SCCA video, he discusses how a treatment called hyperCVAD is making a difference for patients with ALL.
Advertisement Single Below Content
Advertisement Single Below Content
Advertisement Single Below Content